Search

Bruck Kifle

Examiner (ID: 6345, Phone: (571)272-0668 , Office: P/1624 )

Most Active Art Unit
1624
Art Unit(s)
1611, 1624, 1622, 1202
Total Applications
3324
Issued Applications
2505
Pending Applications
197
Abandoned Applications
622

Applications

Application numberTitle of the applicationFiling DateStatus
08/737850 NEW METHODS AND COMPOUNDS FOR THE SELECTIVE MODULATION OF ANTIGEN- SPECIFIC T-CELL RESPONSIVENESS Mar 9, 1997 Abandoned
Array ( [id] => 4229503 [patent_doc_number] => 06074635 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-13 [patent_title] => 'T cell activation' [patent_app_type] => 1 [patent_app_number] => 8/776259 [patent_app_country] => US [patent_app_date] => 1997-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 16 [patent_no_of_words] => 5236 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/074/06074635.pdf [firstpage_image] =>[orig_patent_app_number] => 776259 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/776259
T cell activation Jan 20, 1997 Issued
Array ( [id] => 4181926 [patent_doc_number] => 06159725 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-12 [patent_title] => 'Transformed yeast strains' [patent_app_type] => 1 [patent_app_number] => 8/783045 [patent_app_country] => US [patent_app_date] => 1997-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3428 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/159/06159725.pdf [firstpage_image] =>[orig_patent_app_number] => 783045 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/783045
Transformed yeast strains Jan 15, 1997 Issued
Array ( [id] => 4186939 [patent_doc_number] => 06093693 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-25 [patent_title] => 'B cell activation' [patent_app_type] => 1 [patent_app_number] => 8/746883 [patent_app_country] => US [patent_app_date] => 1996-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 26 [patent_no_of_words] => 14230 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/093/06093693.pdf [firstpage_image] =>[orig_patent_app_number] => 746883 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/746883
B cell activation Nov 17, 1996 Issued
Array ( [id] => 3984624 [patent_doc_number] => 05910306 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-08 [patent_title] => 'Transdermal delivery system for antigen' [patent_app_type] => 1 [patent_app_number] => 8/749164 [patent_app_country] => US [patent_app_date] => 1996-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9269 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/910/05910306.pdf [firstpage_image] =>[orig_patent_app_number] => 749164 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/749164
Transdermal delivery system for antigen Nov 13, 1996 Issued
Array ( [id] => 4187719 [patent_doc_number] => 06160108 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-12 [patent_title] => 'Platelet activation protein' [patent_app_type] => 1 [patent_app_number] => 8/725758 [patent_app_country] => US [patent_app_date] => 1996-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 11424 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/160/06160108.pdf [firstpage_image] =>[orig_patent_app_number] => 725758 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/725758
Platelet activation protein Oct 3, 1996 Issued
08/703825 METHODS FOR IDENTIFYING MODULATORS OF CELLULAR INTERACTIONS MEDIATED BY OSTEOPONTIN Aug 26, 1996 Abandoned
Array ( [id] => 4171817 [patent_doc_number] => 06083751 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-04 [patent_title] => 'Chimeric receptors for the generation of selectively-activatable TH-independent cytotoxic T cells' [patent_app_type] => 1 [patent_app_number] => 8/549846 [patent_app_country] => US [patent_app_date] => 1995-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 16 [patent_no_of_words] => 17483 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/083/06083751.pdf [firstpage_image] =>[orig_patent_app_number] => 549846 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/549846
Chimeric receptors for the generation of selectively-activatable TH-independent cytotoxic T cells Oct 31, 1995 Issued
Array ( [id] => 4109587 [patent_doc_number] => 06045806 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-04 [patent_title] => 'Babesia vaccine' [patent_app_type] => 1 [patent_app_number] => 8/498550 [patent_app_country] => US [patent_app_date] => 1995-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 4719 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/045/06045806.pdf [firstpage_image] =>[orig_patent_app_number] => 498550 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/498550
Babesia vaccine Jul 4, 1995 Issued
Array ( [id] => 4353144 [patent_doc_number] => 06174526 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-16 [patent_title] => 'Blood-borne mesenchymal cells' [patent_app_type] => 1 [patent_app_number] => 8/487116 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6574 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/174/06174526.pdf [firstpage_image] =>[orig_patent_app_number] => 487116 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/487116
Blood-borne mesenchymal cells Jun 6, 1995 Issued
Array ( [id] => 4299687 [patent_doc_number] => 06326004 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-04 [patent_title] => 'Antiviral methods using fragments of human rhinovirus receptor (ICAM-1)' [patent_app_type] => 1 [patent_app_number] => 8/417551 [patent_app_country] => US [patent_app_date] => 1995-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11656 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/326/06326004.pdf [firstpage_image] =>[orig_patent_app_number] => 417551 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/417551
Antiviral methods using fragments of human rhinovirus receptor (ICAM-1) Apr 5, 1995 Issued
Array ( [id] => 4209838 [patent_doc_number] => 06086875 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-11 [patent_title] => 'Receptor specific transepithelial transport of immunogens' [patent_app_type] => 1 [patent_app_number] => 8/374159 [patent_app_country] => US [patent_app_date] => 1995-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7964 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/086/06086875.pdf [firstpage_image] =>[orig_patent_app_number] => 374159 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/374159
Receptor specific transepithelial transport of immunogens Jan 16, 1995 Issued
Array ( [id] => 1419589 [patent_doc_number] => 06514936 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-04 [patent_title] => 'Antiviral methods using human rhinovirus receptor (ICAM-1)' [patent_app_type] => B1 [patent_app_number] => 08/316385 [patent_app_country] => US [patent_app_date] => 1994-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11607 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/514/06514936.pdf [firstpage_image] =>[orig_patent_app_number] => 08316385 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/316385
Antiviral methods using human rhinovirus receptor (ICAM-1) Sep 29, 1994 Issued
09/011148 HUMAN GALECTIN-4-LIKE PROTEIN AND CDNA ENCODING THE SAME - Abandoned
Menu